Bethan Psaila
Overview
Explore the profile of Bethan Psaila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
3314
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benlabiod C, Psaila B
Blood
. 2024 Nov;
144(22):2278-2279.
PMID: 39607716
In this issue of Blood, Reis et al1 identify a monoclonal antibody, INCA033989, that selectively targets mutant calreticulin (mutCALR) in myeloproliferative neoplasms (MPNs), inhibiting its oncogenic activity without affecting normal...
2.
OSullivan J, Omerdeen I, Psaila B
Br J Haematol
. 2024 Nov;
PMID: 39604140
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi-naïve and for those who have previously been treated with a JAKi.
3.
Schattner M, Psaila B, Rabinovich G
Semin Immunol
. 2024 Oct;
74-75:101889.
PMID: 39405834
Hematopoiesis- the formation of blood cell components- continually replenishes the blood system during embryonic development and postnatal lifespans. This coordinated process requires the synchronized action of a broad range of...
4.
Li R, Colombo M, Wang G, Rodriguez-Romera A, Benlabiod C, Jooss N, et al.
Sci Transl Med
. 2024 Oct;
16(768):eadj7552.
PMID: 39383242
Myeloproliferative neoplasms are stem cell-driven cancers associated with a large burden of morbidity and mortality. Most patients present with early-stage disease, but a substantial proportion progress to myelofibrosis or secondary...
5.
Olijnik A, Rodriguez-Romera A, Wong Z, Shen Y, Reyat J, Jooss N, et al.
Nat Protoc
. 2024 Mar;
19(7):2117-2146.
PMID: 38532070
The bone marrow supports and regulates hematopoiesis, responding to physiological requirements for blood cell production over ontogeny and during pathological challenges. Interactions between hematopoietic cells and niche components are challenging...
6.
McLornan D, Psaila B, Ewing J, Innes A, Arami S, Brady J, et al.
Br J Haematol
. 2023 Dec;
204(1):136-150.
PMID: 38037886
No abstract available.
7.
Rampotas A, Carter-Brzezinski L, Somervaille T, Forryan J, Panitsas F, Harrison C, et al.
Blood
. 2023 Nov;
143(2):178-182.
PMID: 37963262
Nonmelanoma skin cancers (NMSCs) in ruxolitinib-treated patients with myeloproliferative neoplasms behave aggressively, with adverse features and high recurrence. In our cohort, mortality from metastatic NMSC exceeded that from myelofibrosis. Vigilant...
8.
McLornan D, Godfrey A, Green A, Frewin R, Arami S, Brady J, et al.
Br J Haematol
. 2023 Nov;
204(1):127-135.
PMID: 37932932
No abstract available.
9.
Reyat J, di Maio A, Grygielska B, Pike J, Kemble S, Rodriguez-Romero A, et al.
Front Cardiovasc Med
. 2023 Sep;
10:1156759.
PMID: 37727305
Introduction: Recent advances in human cardiac 3D approaches have yielded progressively more complex and physiologically relevant culture systems. However, their application in the study of complex pathological processes, such as...
10.
Rodriguez-Meira A, Norfo R, Wen S, Chedeville A, Rahman H, OSullivan J, et al.
Nat Genet
. 2023 Sep;
55(9):1531-1541.
PMID: 37666991
Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)-mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry...